CYCLERION THERAPEUTICS INC CYCN 深 滬
已收盤 02-06 16:00:00 美东时间
1.10
+0.020
+1.85%
華盛通- 最 高1.12
- 今 開1.105
- 成交量 7.67万股
- 最 低 1.06
- 昨 收 1.08
- 總市值 431.78万
- 52周最高 3.79
- 市盈率 靜 --
- 換手率 1.95%
- 52周最低 1.06
- 委 比 -45.99%
- 總股本 392.53万
- 歷史最高 296.60
- 量 比 0.74
- 振 幅 5.56%
- 歷史最低 1.06
- 每 手 1
- 風險率 0.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Watching Cyclerion Therapeutics; Zacks Small-Cap Research Gives Stock $8.00 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_02022026_CYCN_Bautz.pdf
02-03 01:07
Market-Moving News for January 6th
AEVA: 40% | Aeva Technologies' Frequency Modulated Continuous Wave 4D LiDAR Technology Selected For The NVIDIA Drive Hyperion Autonomous Vehicle Reference Platform; Aeva And NVIDIA Will Collaborate To Integrate
01-06 20:11
Cyclerion Therapeutics Collaborates With Medsteer To Integrate Medsteer's Technology Into Cyclerion's CYC-126 Program
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN), a biopharmaceutical company pioneering neuropsychiatric therapies, today announced an application-specific, exclusive collaboration with Medsteer, a leader in anesthetic
01-06 05:02
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
Cyclerion Therapeutics announces a strategic collaboration with Medsteer to advance its CYC-126 program, a novel anesthetic-based therapy for treatment-resistant depression (TRD). The partnership aims to integrate Medsteer's closed-loop anesthetic delivery technology into Cyclerion's platform, enhancing precision and real-time patient feedback. Cyclerion plans to initiate a Phase 2 proof-of-concept study in late 2026. A webcast featuring Dr. Huss...
01-05 21:01
Cyclerion Receives Milestone Payment from Akebia
Cyclerion Therapeutics ( ($CYCN) ) has issued an update. On December 1, 2025, A...
2025-12-02 06:28
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
2025-11-11 20:07
Cyclerion Therapeutics Relaunches with Neuropsychiatric Focus
Cyclerion Therapeutics ( ($CYCN) ) has issued an update. On September 19, 2025,...
2025-09-24 05:13
快讯 | Cyclerion Therapeutics - 根据许可协议，Mit有资格获得高达440万美元的里程碑付款 - SEC文件
Cyclerion Therapeutics - Under License Agreement, Mit Eligible for up to $4.4 M...
2025-09-24 04:19
Cyclerion Announces License Agreement With MIT To Relaunch Advancing Phase 2–Ready Treatment For Resistant Depression
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement –– Webcast to be held September 24, 2025 at 10:30 a.m.
2025-09-24 04:04
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Cyclerion Therapeutics与麻省理工学院达成协议，专注于治疗抵抗性抑郁症的新疗法，II期临床试验计划于2026年启动。2025年9月24日上午10:30，网络直播将讨论这一进展及其未来计划。
2025-09-23 20:01
